Our broad portfolio is the foundation from which we make healthy possible. In the US, our generics portfolio of more than 250 medicines provides affordable access to high quality medicines. Our growing Specialty Pharma business delivers innovative products that meet important medical needs in central nervous system disorders, endocrinology and other therapeutic categories. And we’re working to expand treatment options for institutions, in biosimilars and across select international markets.
